Get the Stockscreener App
3.29
1.86%
0.06
After Hours:
3.34
0.05
+1.52%
Sana Biotechnology Inc stock is traded at $3.29, with a volume of 2.98M.
It is up +1.86% in the last 24 hours and down -42.38% over the past month.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
See More
Previous Close:
$3.23
Open:
$3.21
24h Volume:
2.98M
Relative Volume:
0.62
Market Cap:
$876.34M
Revenue:
-
Net Income/Loss:
$-252.18M
P/E Ratio:
-3.1038
EPS:
-1.06
Net Cash Flow:
$-185.29M
1W Performance:
-17.54%
1M Performance:
-42.38%
6M Performance:
+67.86%
1Y Performance:
+40.00%
1-Day Range:
$3.16
$3.3779
1-Week Range:
$3.16
$3.98
52-Week Range:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
Name
Sana Biotechnology Inc
Sector
Industry
Phone
(206) 701-7914
Address
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Compare SANA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.29 | 860.36M | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Initiated | Wedbush | Outperform |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Mar-18-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Mar-14-25 | Initiated | Jefferies | Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Nov-05-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Rodman & Renshaw | Buy |
| Jan-16-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-25-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-05-23 | Initiated | Citigroup | Buy |
| Aug-14-23 | Initiated | TD Cowen | Market Perform |
| May-02-23 | Initiated | H.C. Wainwright | Neutral |
| Mar-01-21 | Initiated | BofA Securities | Buy |
| Mar-01-21 | Initiated | Goldman | Neutral |
| Mar-01-21 | Initiated | JP Morgan | Neutral |
| Mar-01-21 | Initiated | Morgan Stanley | Overweight |
View All
Sana Biotechnology Inc Stock (SANA) Latest News
Why Sana Biotechnology Inc. stock could benefit from AI revolutionWatch List & Fast Gaining Stock Strategy Reports - newser.com
Can Sana Biotechnology Inc. stock deliver surprise earnings beat2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
How Sana Biotechnology Inc. stock benefits from global expansion2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Evaluating Sana Biotechnology Inc. with trendline analysisJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
What valuation multiples suggest for Sana Biotechnology Inc. stock2025 Big Picture & Free AI Powered Buy and Sell Recommendations - newser.com
Using Ichimoku Cloud for Sana Biotechnology Inc. technicalsJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Will Sana Biotechnology Inc. stock benefit from automationBull Run & Daily Risk Controlled Trade Plans - newser.com
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care - FinancialContent
Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength - Yahoo Finance
Can Sana Biotechnology Inc. recover in the next quarterTreasury Yields & Fast Exit and Entry Trade Guides - newser.com
Can Sana Biotechnology’s (SANA) Leaner Cost Structure Strengthen Its Long-Term Competitive Position? - Yahoo Finance
Sana Biotechnology Beats Expectations in Q3 Report - StocksToTrade
Identifying reversal signals in Sana Biotechnology Inc.Fed Meeting & Accurate Entry/Exit Alerts - newser.com
Why Sana Biotechnology Inc. stock is a must watch in 20252025 Geopolitical Influence & Risk Controlled Daily Trade Plans - newser.com
Sana Biotechnology Beats Earnings Expectations, Gains Investor Confidence - timothysykes.com
Is Sana Biotechnology Inc. stock a smart buy before Fed meetingWeekly Gains Report & Fast Exit and Entry Trade Guides - newser.com
Earnings visualization tools for Sana Biotechnology Inc.2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
Sana Biotechnology’s Q3 Reports Beat Expectations, Stock Target Raised to $8 - StocksToTrade
Is Sana Biotechnology's (SANA) Ongoing Loss Reduction Shaping Its Long-Term Investment Narrative? - simplywall.st
Custom strategy builders for tracking Sana Biotechnology Inc.Gap Up & Safe Capital Allocation Plans - newser.com
Visual trend scoring systems applied to Sana Biotechnology Inc.2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com
What MACD signals say about Sana Biotechnology Inc.July 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Long term hold vs stop loss in Sana Biotechnology Inc.Earnings Growth Summary & Stock Portfolio Risk Control - newser.com
Using economic indicators to assess Sana Biotechnology Inc. potentialJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
All You Need to Know About Sana (SANA) Rating Upgrade to Buy - sharewise.com
Sana Biotechnology Inc Stock (SANA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):